EssilorLuxottica (EL) EUR 0.35
€1.40
(0.60%)
- Add to watchlist
- This stock can be held in a
€1.40
(0.60%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
€1.40
(0.60%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Business summary
EssilorLuxottica SA is a France-based ophthalmic company. The Company designs, distributes, manufactures, and markets a range of lenses, frames, and sunglasses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals. It operates through three segments: Lenses and Optical Instruments, which includes corrective lenses, optical instruments intended for opticians and optometrists; Equipment, which includes machines and consumables used by plants and prescription laboratories, and Sunglasses & Readers, which encompasses non-prescription reading glasses and non-prescription sunglasses. EssilorLuxottica's assets include recognized brands, such as Ray-Ban and Oakley for eyewear, Varilux and Transitions for ophthalmic optical technologies, and Sunglass Hut and Lenscrafters for international distribution networks.
Contact details
Important dates
General stock information
- Short code:
- EL
- ISIN:
- FR0000121667
- Market cap:
- €106.92 billion
- Shares in issue:
- 456.14 million
- Sector:
- Health Care Supplies
- Exchange:
- Euronext Paris
- Country:
- France
- Currency:
- Euro
- Indices:
- Paris CAC 40
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.